Results from the Phase 2 PHAROS trial potentially establish new benchmark with targeted combination therapies for this patient population
This new suite of products demonstrates Nouryon’s leadership in cleaning ingredient solutions
Speakers for the Session are: Venkata Prasad K., Unit Head, Deepak Nitrite; Abhilash Pasham, Associate General Manager - Central Engineering & Projects, Dr. Reddy's Laboratories; C. V. Rajulu, Consultant, Industry; and Jyoti Shankar Jha, Senior Lead Scientist, Alleima India. The moderator for the Session is Pravin Prashant, Executive Editor, Indian Pharma Post
Lilly's Omvoh is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
Alembic receives EIR from USFDA for facility at Panelav
Hemant Surgical Industries receives order
The Ma’anshan site approval covers pastilles, oral liquids, and powders
Combination creates a leading, next generation claims operating system for payers, with end-to-end AI capabilities for claims, payments, care & utilization management, payment integrity, and member engagement, serving 115+ health plans
Subscribe To Our Newsletter & Stay Updated
